RxSight, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of the 2023 Annual Meeting of Stockholders held on June 1, 2023. RxSight, Inc. is a Delaware corporation with its principal executive offices in Aliso Viejo, California. The company is classified as an emerging growth company.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and voting results.
Material Changes and Voting Results
Of the 33,972,617 shares outstanding as of April 10, 2023, 29,609,932 shares (approximately 87.2%) were represented at the meeting. The following matters were approved:
- Election of Directors: Three Class II directors were re-elected to serve until the 2026 annual meeting:
- William J. Link, Ph.D. (24,161,853 votes For)
- Robert Warner (21,883,075 votes For)
- Shweta Singh Maniar (21,198,960 votes For)
- Charter Amendment: An amendment to the certificate of incorporation to reflect new Delaware law provisions regarding officer exculpation was approved (22,214,405 votes For).
- Auditor Ratification: The appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2023, was ratified (29,491,614 votes For).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the re-election of the three Class II directors and their tenure through 2026.
- Confirm the implementation of the charter amendment regarding officer exculpation under new Delaware law.
- Note the ratification of Ernst & Young LLP as the auditor for the 2023 fiscal year.
- Review the high level of shareholder participation (87.2%) and the specific vote counts for each proposal.